Collins Charles Edwin IV's Form 4/A amendment
AmendedArgan IncAGX · filed Aug 29, 2025
- Accession no.
- 0001415889-25-023298
- Filed
- Aug 29, 2025
- Trade date
- Jul 29-31, 2025
- Filing delay
- 31 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Aug 1, 2025
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.59M. It was filed 31 days after the trade.
This amendment replaces 0001415889-25-020876 (filed Aug 1, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Collins Charles Edwin IVCIK 0001791800 | Officer (CHIEF EXECUTIVE OFFICER, GEMMA) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2025 | Common Stock | MOption exerciseAcquired | +1,500 | $46.35 | +$69,525 | 22,506 | Direct | |
| Jul 29, 2025 | Common Stock | SSaleDisposed | −1,500 | $241.50 | −$362,250 | 21,006 | Direct | |
| Jul 31, 2025 | Common Stock | MOption exerciseAcquired | +2,735 | $46.35 | +$126,767.25 | 23,741 | Direct | |
| Jul 31, 2025 | Common Stock | MOption exerciseAcquired | +2,265 | $43.10 | +$97,621.5 | 26,006 | Direct | |
| Jul 31, 2025 | Common Stock | SSaleDisposed | −5,000 | $245.00 | −$1,225,000 | 21,006 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2025 | Common Stock | MOption exerciseDisposed | −1,500 | $46.35 | −$69,525 | 57,235 | Direct | |
| Jul 31, 2025 | Common Stock | MOption exerciseDisposed | −2,735 | $46.35 | −$126,767.25 | 54,500 | Direct | |
| Jul 31, 2025 | Common Stock | MOption exerciseDisposed | −2,265 | $43.10 | −$97,621.5 | 52,235 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On July 29, 2025 the Reporting Person exercised a portion of his stock option awarded on January 11, 2018 to purchase 1,500 shares of the Issuer's common stock at price of $46.35 per share.
- F2
On July 29, 2025 the Reporting Person sold 1,500 shares of common stock on the open market at an average price of $241.50 per share.
- F3
On July 31, 2025, the Reporting Person exercised the remainder of his stock option awarded on January 11, 2018 to purchase 2,735 shares of the Issuer's common stock at a price of $46.35 per share.
- F4
On July 31, 2025, the Reporting Person exercised a portion of his stock option awarded on September 12, 2018 to purchase 2,265 shares of the Issuer's common stock at a price of $43.10 per share.
- F5
On July 31, 2025, the Reporting Person sold 5,000 shares of the Issuer's common stock on the open market at an average price of $245 per share.